dopa

dopa

1. The SPECT imaging with 123 I AIBZM reflected the functional actitvity of striatal D 2R and might be valuable for predicting the patients' response to L dopa, especially D 2R agonist therapy for Parkinson's disease.

12 3I AIBZMSPECT显像能反映D2 R功能状态 ,可能是预测PD患者对左旋多巴 ,尤其是D2 R激动剂治疗反应性的一个指

2. 3,4-dihydroxyphenylalanine, DOPA

3,4－二羟苯丙氨酸, 多巴

3. 4 - quinone( DOPA quinone)

4-醌（DOPA醌）

4. CoSalphen Immobilized onto Chitosan and its Activate in Catalytic Oxidation of DOPA

CoSalphen在壳聚糖上的固定化及对DOPA的催化氧化研究

5. The linearity was investigated by adding the racemic compound to the standard L-enantiomer of dopa in the range of 0.1~2.0%. The concentration of D-dopa in levdopa is 0.20% by tested.

D-多巴含量在0.1~2.0%范围内具有良好的线性关系(R2=0.9990),并测定左旋多巴的光学杂质为0.2%。

6. 4 ) DOPA staining: The staining was performed with 0.1% L - DOPA solution in frozen sections.

DOPA染色：用0.1%L-DOPA染液进行染色。

7. Study on the induction of apoptosis and the expression of apoptosis related gene in catecholaminergic PC12 cells by L dopa

L-dopa诱导PC12细胞凋亡及相关基因表达的实验研究

8. After L dopa therapy,the level changes were enhanced ?(P<0.05)?.

L-多巴治疗后 ,NO、NOS、SOD、GSH-Px进一步降低 ,LPO进一步增高 (P <0 .0 5 )。

9. DOPA, dopa

[化] 多巴

10. dopa reaction

[医] 二羟苯基丙氨酸反应

11. dopa decarboxylase

[医] 多巴脱羧酶, 二羟苯基丙氨酸脱羧酶

12. Keywords RUQUAN GRANULE;l dopa;galactagogue effect;prolactin;

乳泉颗粒剂;左旋多巴;催乳作用;催乳素;

13. After in taking 350mg of L dopa,timed test and non timed test were done every 30 minutes.

先停药 12小时以上 ,然后 ,一次性口服左旋多巴 35 0mg ,每隔 30分钟对病人的状态评价一次 ,共计检查 30 0分钟 ;

14. cysteinyl dopa

半胱氨酰多巴

15. SIMULTANEOUS DW SPECTROPHOTOMETRIC DETERMINATION OF TYROSINE AND DOPA

双波长吸光光度法同时测定多巴和酪氨酸的研究

16. PRODUCTION OF L DOPA BY IMMOBILIZED PSEUDOMONAS SP.

固定化假单胞菌产L-多巴

17. A similar increase was shown in those of the intact animals given an inhibitor of high affinity dopamine uptake, GBR 12909 (20 mg/kg, i.p.) , in response to DOPA.

在使用多巴胺高亲和力重摄取位点的阻断剂GBR12909后，左旋多巴治疗正常动物也引起了类似于帕金森病动物的变化。

18. The unchanged 18 F dopa in plasma determined at various intervals in MPTP treated monkeys was higher than that in the controls.

在各个时间点测得血浆未代谢18F?多巴皆高于对照组。

19. Based on the comparisons with the sequences of dopa decarboxylase (DDC) gene of Heliothinae, two pairs of the primer were designed. A specific 730bp fragment was obtained by PCR amplification.

在比较实夜蛾亚科昆虫多巴脱羧酶(DDC)基因的基础上,根据同源序列,设计了2对引物,利用PCR扩增获得了一条730bp的特异性片段,以此作为探针。

20. Responses of Growth Hormone and Prolactin to L Dopa in Women with Polycystic Ovarian Syndrome

多囊卵巢综合征患者血清生长激素和泌乳素对左旋多巴反应的研究

21. in dopa

多巴

22. dopa responsive dystonia

多巴反应性肌张力障碍

23. Dopa responsive dystonia of seven cases

多巴反应性肌张力障碍七例报告

24. UV-Vis Spectroscopic Study of Aluminum-Manganese Cooperative Effect on the Melanin Formation from DOPA Oxidation

多巴氧化生成黑色素过程中锰和铝协同作用的紫外-可见光谱研究

25. dna dopa oxidase

多巴氧化酶

26. DopA method

多巴氧化酶法

27. Dopa aminotransferase

多巴氨基转移酶

28. Research Advance of DOPA Drugs

多巴类药物的研究进展

29. A monoamine neurotransmitter formed in the brain by the decarboxylation of dopa and essential to the normal functioning of the central nervous system. A reduction in its concentration within the brain is associated with Parkinson's disease.

多巴胺由多巴的脱羧产物，在大脑中形成单胺神经传递素，是中枢神经系统正常运行的必要因素。在大脑中的浓度降低会引起帕金森氏病

30. a monoamine neurotransmitter formed in the brain by the decarboxylation of dopa and essential to the normal functioning of the central nervous system. A reduction in its concentration within the brain is associated with Parkinson's disease

多巴胺，由多巴的脱羧产物，在大脑中形成单胺神经传递素，是中枢神经系统正常运行的必要因素。在大脑中的浓度降低会引起帕金森氏病

31. dopa decarboxylase, DDC

多巴脱羧酶

32. dopa decarboxylase inhibitor

多巴脱羧酶抑制剂(类)

33. Changes of dopamine receptors in vascular smooth muscles after oral L dopa

大鼠长期服用左旋多巴后血管平滑肌中多巴胺受体变化的观察

34. It catalyzes the oxidation of dopa rapidly to dopaquinone, which in turn polymerize non-enzymetically into insoluble melanin.

它是一种含铜的酶,能够催化单酚羟化成二酚(如多巴),把二酚氧化成醌;

35. Keywords L Dopa（3;4 dihydroxyphenylalanine）;Aluminum;Differential pulse voltammetry;

左旋多巴;铝;示差脉冲伏安法;

36. Levo- dopa and the Parkinson's Disease

左旋多巴与帕金森氏病

37. The levorotatory form of dopa, used to treat Parkinson's disease.

左旋多巴左旋形式的多巴，用于治疗帕金森综合症

38. The levorotatory form of dopa,used to treat Parkinson's disease.

左旋多巴左旋形式的多巴，用于治疗帕金森综合症。

39. The effect of L dopa short term " drug holiday" in the patients with Parkinson disease

左旋多巴类药物短期“休假”在帕金森病治疗中的应用

40. Levo dopa(L-DOPA)

左旋多巴（L-DOPA）

41. The change of blood antioxidant function in Parkinson disease and the effect of Dopa and Vit E on it

帕金森病患者血液抗氧化功能的变化及多巴制剂与VitE对其影响的研究

42. A new method for enantioseparation of dopa was established. Then,we applied this method to the optical purity testing of dopa.

建立了多巴手性分离新体系,并应用于左旋多巴光学纯度检测。

43. Neuroblastomas are also associated with increased urinary levels of dopa, dopamine and their metabolites

成神经细胞瘤患者尿中也出现大量的多巴、多巴胺以及它们的代谢物。

44. Neuroblastomas are also associated with increased urinary levels of dopa, dopamine and their metabolites, particularly homovanillis acid.

成神经细胞瘤患者尿中也出现大量的多巴、多巴胺以及它们的代谢物，特别是高香草酸。

45. The results suggested that the patients with PD were lower in the activity of the antioxidant and the metabolism of lipid peroxides was excessively,the Dopa medicine might excited the course which Vit E couldn't effect it on.

提示 PD患者伴有抗氧化酶活性降低 ,过氧化脂质代谢增强 ,但病程早期并不显著 ,而多巴制剂、特别是 L-多巴可加速这一变化过程 ,Vit E对其无影响

46. METHODS: Tyrosinase activity was estimated by measuring the oxidation rate of L DOPA.

方法 :酪氨酸酶多巴速率氧化法体外测定药物干预前后酪氨酸酶活性 ,求出酪氨酸酶抑制率。

47. METHODS: The models of hypoprolactinemia were established with L dopa in rats.

方法 :采用左旋多巴 (L Dopa)诱导建立哺乳大鼠乳汁分泌低下模型 ;

48. Mothods L dopa tests were conducted in 33 cases with PD,after UPDRS rating and Webster rating.

方法 对 33例PD病人 ,在进行UPDRS评分和Webster评分后 ,作一次单剂量左旋多巴试验。

49. Methods:The standard strains were grown on L dopa and bird seed medium.The fragment of CNLAC1 was analyzed by random amplification of genomic DNA.

方法:取标准的产黑素和白化突变菌株分别培养,研究产黑素表型的变化,并用聚合酶链反应进行CNLAC1目的基因片段的扩增。

50. METHODS:The experiment was conducted in the Laboratory for Toxicology,Fujian College of Traditional Chinese Medicine from January to May 2004.The activity of tyrosinase was estimated by measuring the oxidation rate of DL dopa.

方法:实验于2004-01/05在福建中医学院毒理实验室完成,采用蘑菇酪氨酸酶多巴速率氧化法检测酪氨酸酶活性。

51. Methods 24 kinds of plant were selected,using DOPA as substrate, adding plant extracts and mushroom tyrosinase,measuring A475 and calculating the percentage inhibition of tyrosinase.

方法选用24种植物,以多巴为底物,加入植物提取物和蘑菇酪氨酸酶,测定A475,计算酪氨酸酶的抑制百分率。

52. 6.Methods 24 kinds of plant were selected,using DOPA as substrate, adding plant extracts and mushroom tyrosinase,measuring A475 and calculating the percentage inhibition of tyrosinase.

方法选用24种植物,以多巴为底物,加入植物提取物和蘑菇酪氨酸酶,测定A475,计算酪氨酸酶的抑制百分率。收藏指正

53. The amount of dopa mine in group C was higher than that of group HL after aorta off-clamping within 24 hours(P<0.01).

术后24h多巴胺用量,观察组明显低于对照组(P<0.01)。

54. The content of Dopa was 0.76%(g/g) RSD=2.18%.

样品中二羟基苯丙氨酸的含量为 0 .76% (g/ g) ,RSD=2 .18%。

55. Experimental studies of early diagnosis of parkinson disease using positron emission tomography/ 18 F dopamine receptor imaging and measurement of 18 F dopa radioactivity in plasma

正电子发射计算机断层显像/~(18)F-多巴胺受体显像和血浆~(18)F-多巴放射性测定早期诊断帕金森病的实验研究

56. Determination of Dopa in Portulaca Oleracea by High Performance Capillary Electrophoresis

毛细管电泳法测定马齿苋中二羟基苯丙氨酸的含量

57. Keywords fluoro L DOPA;chiral catalyst;phase transfer alkylation;entiomeric purity;HPLC method;chiral mobil phase;

氟-L-多巴;手性催化剂;相转移烷基化;对映纯度;HPLC法;手性流动相;

58. Study on Novel Methods for Enantiomeric Separation of Amino Acids and Dopa by Capillary Electrophoresis

氨基酸和多巴对映体的毛细管电泳手性拆分新体系研究

59. Indirect Differential Pulse Voltammetric Determination of Aluminum in Biological Samples with L Dopa

用左旋多巴-示差脉冲伏安法间接测定生物样品中的铝

60. methyl dopa

甲基多巴

61. medomet methyl dopa

甲基多巴, 爱道美

62. Chiral separation of dopa methyl ester hydrochloride enantiomers by HPCE

盐酸多巴甲酯对映体的HPCE手性拆分

63. L - dopa methyl ester hydrochloride

盐酸左旋多巴甲酯

64. Objective: To observe the effect of chronic levodopa (L dopa) administration on striatal prodynorphin mRNA expression in a rat model of Parkinson disease (PD), and probe into the pathogenesis of L dopa induced dyskinesias (LID).

目的 :观察左旋多巴 (L dopa)治疗对帕金森病 (PD )大鼠纹状体强啡肽原表达的影响 ,探讨L dopa诱发异动症 (LID)的机制。

65. Objective To introduce L dopa test into the preparation of the surgical intervention of PD.

目的 介绍左旋多巴试验在PD外科治疗中的应用价值。

66. Objective To evaluate the tetrahydrobiopterin(BH 4) metabolism,gene mutation and clinical manifestation in patients with dopa responsive dystonia(DRD).

目的 探讨多巴反应性肌张力障碍 (DRD)其四氢生物蝶呤 (BH4)代谢及基因突变与临床表型关系。

67. Objective To explore the clinical feature and treatment method of the dopa responsive dystonia (DRD).

目的 探讨多巴反应性肌张力障碍的临床特点及治疗。

68. Objective To explore the activities and the level of antioxidant system in Parkinson disease (PD) and the effect of L dopa and Vit E on it,and find the indications of oxidative stress in PD.

目的 探讨帕金森病 (PD)的抗氧化酶 (SOD)活性和过氧化脂质 (L PO)代谢水平的变化和多巴药物及 Vit E对其的影响 ,找出反映氧化异常的客观生化指标。

69. Objective To study the neurotoxicity of L dopa and its neuroprotective method.

目的 研究左旋多巴 (L- dopa)的神经毒性及其神经保护方法。

70. Objective To observe the change of antioxidant system in Parkinson disease(PD) and the influence of L dopa.

目的 观察帕金森病 (PD)血抗氧化系统变化及 L-多巴的影响。

71. Objective:To evaluate the neuronal toxicical effects induced by L-dihydroxy-phenylanine (L-dopa) and to explore the method by which Parkinson disease(PD) can be treated reasonablely with L- dopa.

目的:研究左旋多巴(L-dopa)对黑质细胞的神经毒性作用,探讨合理应用L-dopa治疗帕金森病(Parkinson disease,PD)的方法。

72. Objective To improve sensitivity,specificity and stability of spectrophotometric assay for the dopa oxidase activity of tyrosinase.

目的提高分光光度法检测酪氨酸多巴氧化酶活性(多巴氧化酶)的灵敏度、特异性和稳定性。

73. Furthermore, the BSA-based approach was also used to predict the enantiomeric composition of other chiral compounds: phenylalanine, tyrosine, alanine, cysteine, DOPA, and propranolol.

研究对象为较低浓度范围的手性化合物，实验和分析方面同第三章。

74. Simultaneous determination of dopa, epinephrine and dopamine with the ion chromatograph and fluorescent detector

离子色谱-荧光检测器同时测定多巴、肾上腺素和多巴胺

75. Keywords Stopped spectrophotometric assay;Dopachrome assay;Continuous spectrophotometric assay;Dopa oxidase;

终止分光光度法;多巴色素法;连续监测法;多巴氧化酶;

76. No statistical difference was observed in the improvement percentages of CBPVP, SBPVP1 and SBPVP2. CBPVP contributed greatly to L dopa induced side effects (part IV).

结果 CBPVP、SBPVP1以及SBPVP2均明显改善患者的整体病情和典型症状 (震颤、僵直和行动迟缓 ,P <0 0 0 1) ,它们对“关”状态的改善总是高于对“开”状态的改善。

77. The second time and third time which added Dopa medicine and Vit E,the activity of P SOD and GSH Px were obviously declined,and the levels of LPO and MDA were increased in the A group.

结果 未服用药物患者的血抗氧化酶活性基本正常 ,加服 L-多巴后 P- SOD、GSH- Px降低 ,L PO和 MDA水平明显升高。

78. 5.The result points out the positive dopa melanin cells are densfied via their own splitting vegetation and the activation of the inactive melanin cells;

结果提示，多巴阳性黑色素细胞通过其本身的分裂增殖及无活性黑色素细胞的活性化而实现密度的增加；

79. Keywords Gastric cancer;Dopa decarboxylase;Peritoneal metastasis;

胃癌;多巴脱羧酶;腹膜转移;

80. Effect of bilateral subthalamic nucleus stimulation on dopa responsiveness in parkinsonism and levodopa-equivalent dose

脑深部电刺激器对帕金森病多巴反应性和左旋多巴等效剂量的影响